Raportul
Știri verificate despre finanțări, sedii centrale și leadership de la cele mai inovatoare companii din lume
4 rapoarte și mai multe
Ratio Therapeutics Raises $70M Series C for Targeted Radiotherapeutics
Ratio Therapeutics closed a $70 million Series C financing with existing and new investors and expects to use the funding to advance its ongoing ATLAS study and move its next-generation RLT candidate into the clinic.
AdvanCell Raises $315M Series D for Targeted Alpha Therapies
AdvanCell closed an oversubscribed, upsized $315 million Series D led by Ally Bridge Group and co-led by Alpha Wave to advance ADVC001 toward Phase 3 and expand U.S. manufacturing.
Artbio raises $132M Series B
Artbio raises $132M in Series B. Radiopharmaceutical company developing targeted cancer therapies...
Cellectar Biosciences Headquarters - Office Location & Address
Discover Cellectar Biosciences's headquarters at 100 Campus Dr, Madison, WI 53717. Radiopharmaceutical developer. Learn about the office facilities and work environment.
Afișare 4 rapoarte • Pagina 1 • Categorie: all
Rămâneți înaintea pieței
Primiți perspective săptămânale în inbox. Fără spam, doar inteligență.